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Abstract
Melatonin receptors interact with pertussis toxin-sensitive G proteins to inhibit adenylate cyclase. However, the G protein coupling profiles
of melatonin receptor subtypes have not been fully characterised and alternative G protein coupling is evident. The five C-terminal residues of
Ga subunits confer coupling specificity to G protein-coupled receptors. This report outlines the use of Gas chimaeras to alter the signal output of
human melatonin receptors and investigate their interaction with the C-termini of Ga subunits. The Gas portion of the chimaeras confers the
ability to activate adenylate cyclase leading to cyclic AMP production. Co-transfection of HEK293 cells expressing MT1 or MT2 melatonin
receptors with Gas chimaeras and a cyclic AMP activated luciferase construct provided a convenient and sensitive assay system for
identification of receptor recognition of Ga C-termini. Luciferase assay sensitivity was compared with measurement of cyclic AMP elevations
by radioimmunoassay. Differential interactions of the melatonin receptor subtypes with Ga chimaeras were observed. Temporal and kinetic
parameters of cyclic AMP responsesmeasured by cyclic AMP radioimmunoassay varied depending on theGas chimaeras coupled. Recognition
of the C-terminal five amino acids of the Ga subunit is a requisite for coupling to a receptor, but it is not the sole determinant.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: Melatonin receptor; G protein-coupled receptor; Ga chimaera
1. Introduction
G protein-coupled receptors conduct intracellular signal-
ling through coupling to the Ga subunits of heterotrimeric G
proteins in cell membranes. There are at least 17 Ga subunits
that have been grouped into distinct classes based on
sequence homology. Each has the ability to activate a down-
stream effector molecule with subsequent activation of a
cascade of intracellular signalling events [1]. Identification
of the G protein coupling specificity of a G protein-coupled
receptor is a necessary requisite to identifying signalling
events regulated by a particular receptor and allows an in-
sight into the possibilities for receptor regulation of signal-
ling pathways in complex cell environments.
The G protein-coupled melatonin receptors have been
identified in a number of different tissues [2–5]. They are
activated by the hormone melatonin, synthesised primarily
by the pineal gland during the hours of darkness and
regulate seasonal and circadian rhythms [6]. The signalling
systems regulated by the melatonin receptors are poorly
understood, particularly in fetal tissue and peripheral sites.
Based on sequence similarities, three melatonin receptor
subtypes have been identified: MT1, MT2 and mel1c [3,7,8].
Only MT1 and MT2 are expressed in mammals and all three
subtypes are found in chicken, Xenopus and zebrafish. In
native cells, the coupling of melatonin receptors and their
interaction with different signalling systems is poorly
defined. Melatonin has the ability to inhibit forskolin-
stimulated cyclic AMP production in a number of native
tissues [9]. In some cases, this event is sensitive to pertussis
toxin (PTX) and this suggests that the melatonin receptors
are coupled to Gi or Go proteins [10–14]. Since Gi
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mediates the inhibition of cyclic AMP it has been presumed
that the G protein involved is Gai1, Gai2 or Gai3. In
addition, PTX-insensitive adenylyl cyclase inhibition of
cyclic AMP has been observed in the sheep pars tuberalis
[15,16]. Coupling of Xenopus mel1c subtypes to Gz [17]
and coupling of MT1 to Gq [18] have been reported.
Melatonin receptor activation of cyclic AMP through cou-
pling to Gas is unknown. However, the involvement of G
protein coupling and activation of PTX-insensitive path-
ways has not undergone thorough investigation.
There is considerable evidence to substantiate the impor-
tance of the extreme C-terminus of the Ga subunits in
mediating contact and coupling specificity with G protein-
coupled receptors [19–21]. Subsequently, researchers have
reported that the C-terminal five amino acid residues can
confer G protein-coupled receptor coupling specificity
within cell membranes.
Using the ability of the C-terminal five amino acid
residues of Ga to confer G protein coupling specificity, G
protein coupling profiles were obtained for the human
melatonin receptors, MT1 and MT2. Chimeric Gas subunits
were generated that allow reversal of melatonin inhibition of
cyclic AMP to activation of cyclic AMP. The Gas subunit
contact effector site is located at the N-terminal hence cyclic
AMP stimulation by this subunit is unaffected by C-terminal
changes [22,23]. Gas subunit activation of cyclic AMP
generates a robust signal that is more easily measured since
measurement of cyclic AMP inhibition often requires pre-
stimulation with forskolin. The paradoxical cyclic AMP
stimulation of Gas–ax chimaeras (where ax is the C-
terminal five residues of the known Ga subunits) by cyclic
AMP inhibitory melatonin receptors also provides an oppor-
tunity to obtain incontrovertible evidence of Gas–ax chi-
maera coupling. Cell lines stably expressing the melatonin
receptors were co-transfected with wild-type Gas or Gas–
ax chimaeras and a cyclic AMP responsive luciferase
reporter construct. Receptor–Gas–ax chimaera coupling
in response to melatonin was then measured via stimulation
of cyclic AMP and activation of luciferase monitored by a
luminescent assay. Cyclic AMP levels were also measured
by radioimmunoassay in the Gas–ax chimaera transfected
cell lines to determine temporal and kinetic differences in
receptor–Gas–ax coupling efficiency to the different Ga
C-termini between the MT1 and MT2 receptor subtypes.
2. Methods
2.1. Materials
All chemical reagents were obtained from Sigma Interna-
tional, UK, unless otherwise stated. Restriction and DNA
modifying enzymes and enzyme buffers were obtained from
Promega, Southampton, UK. Cell culture media, sera and
antibiotics were obtained from Gibco Invitrogen Corpora-
tion, Paisley, UK. Random and synthetic oligo primers were
purchased from Genosys, Cambridgeshire, England. Anti-
bodies were obtained from Santa Cruz Biotechnology.
2.2. Construction of Gas–ax chimaeras
First strand cDNA prepared from HEK293, as described
previously [24], was used as a template to generate a Gas
subunit cDNA minus the C-terminal 15 bases encoding the
last five amino acids. PCR was performed using 100 pmol
of primers (5V-gcaagcttgccgccgccatgggctgc-3V, 5V-acgaaggtg-
catgcgctgaatgatg-3V), 2.5 U Turbo Pfu polymerase (Gib-
coBRL, Paisley, Scotland) and 200 AM dNTPs. The PCR
reaction cycles consisted of 94 jC for 1 min, 65 jC for 1
min and 74 jC for 3 min for 30 cycles. The PCR product
was cleaved at the 5Vend with HindIII. Oligo pairs encoding
the C-terminal five amino acids of the known Ga subunits
were annealed by incubating 500 pmol of each oligo at 100
jC for 1 min in 0.15 M NaCl and allowing to cool to room
temperature. The annealed oligo pairs generated double-
stranded fragments (see Fig. 1) that were ligated to the Gas
PCR product. Ligation of the truncated Gas PCR product
and the annealed oligo pairs was designed to facilitate
subcloning of the Gas chimeric constructs directly into a
HindIII/KpnI cleaved mammalian expression vector
pcDNA3.1 (Gibco Invitrogen). The resulting chimaeras
were sequenced using DNA prepared by a Wizard DNA
purification kit (Promega) and an Applied Biosystems
model 377 DNA sequencer.
2.3. Cell culture and transfection
The HEK293 cell lines stably expressing the human MT1
(HEKh1a) and MT2 (HEKh1b) receptors and HEK293
culture were described previously [24]. Cells were transi-
ently co-transfected with pGL3(CRE2-TK) [25] and a Gas–
x chimaera cloned in pcDNA3.1 (Gibco Invitrogen) or an
equivalent amount of pcDNA3.1 plasmid. The plasmid,
pGL3(CRE2-TK), consisted of the luciferase reporter,
pGL3 (Promega) with a thymidine kinase (TK) basal
promoter and two cyclic AMP responsive elements (CRE)
cloned upstream of the TK promoter as described previously
[25]. Cells were transfected at around 80% confluence on 90
mm plates with 2 Ag of each plasmid to be transfected and 3
Al FuGENE 6/Ag DNA according to the manufacturers
instructions (Boehringer Mannheim).
2.4. Immunodetection of Gas chimaera expression
Membrane proteins were extracted from cells transfected
as described above, 48 h after transfection. Cells were rinsed
with 1 PBS and pelleted at 700 g for 10 min. The cells
were stored at  70 jC prior to extraction of membrane
proteins as follows. Cell pellets were resuspended in 0.5 ml
homogenate buffer (10 mM Tris pH 7.5, 1 mM EGTA) and
homogenised using a glass homogeniser. The homogenate
was made up to a volume of 1 ml with homogenate buffer
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and spun at 500 g (Juoan) for 15 min. The supernatant
was then spun at 38,000 rpm (TL100) for 5 min. The pellet
was resuspended in 1 ml of homogenate buffer and spun
38,000 rpm for a further 5 min before resuspending in 1 ml
of homogenate buffer. An aliquot was removed for quanti-
tation using a Biorad DC protein assay kit.
For each transfected Gas chimaera, 20–50 Ag of mem-
brane proteins were separated on a 10% polyacrylamide gel
in the presence of SDS and electrophoretically transferred to
poly-(vinylidene difluoride) (PVDF) membrane. Immuno-
detection of recombinant Gas and the Gai3 by a Gas (C-
terminal) and a Gai3 (C-terminal) antibody, respectively,
was visualised by chemiluminescence using an ECL kit
(Amersham).
2.5. Ribosylation of Gas chimaeras
Membrane proteins isolated as described above were
assayed for the presence of Gas short-form chimaeras by
ribosylation with cholera toxin in the presence of [32P]NAD
as described by Morgan et al. [26]. Briefly, 50 Ag membrane
protein was incubated for 30 min at 37 jC with 10 mM
thymidine, 1 mM ATP, 2 mM GTP, 10 AM NAD, 20 ACi
[32P]NAD (specific activity 800 ACi/mmol; NEN) with or
without cholera toxin at 120 Ag/ml in 150 mM sodium
phosphate pH 7.5, 2.5 mM MgCl2, 1 mM EDTA. The
reactions were centrifuged at 4 jC to pellet the ribosylated
products and electrophoresed by SDS-PAGE (12.5% sepa-
rating gel; 6% stacking gel). The SDS-PAGE gels were
dried and apposed to film (KODAK X-OMAT).
2.6. Assay of luciferase activity
Cells transfected with pGL3(CRE2-TK) and either a
blank pcDNA3.1 plasmid or a Gas chimaera were trypsi-
nised and seeded into 96-well view plates (Packard) at
40,000 cells per well the day following transfection. The
remaining cells were reseeded onto 90 mm plates and
Fig. 1. Construction of the Gas chimaeras. The constructed Gas wt representing the S1 form of human Gas and the Gas–ax chimaeras with the annealed
oligos used to reconstruct the sequence encoding the C-terminal five residues of Gas wt are shown.
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harvested the following day for protein extraction and
Western blotting or ribosylation assay to determine Gas
chimeric expression in the transfected cells. The day follow-
ing seeding into 96-well plates, the cells were stimulated
with or without melatonin, or forskolin. The cells were
stimulated at 37 jC for 16–18 h. The induced adenylate
cyclase activity was then measured using the Luclite luci-
ferase reporter gene assay system (Boehringer Mannheim)
according to the manufacturers instructions and a lumin-
ometer (Packard).
2.7. Radioimmunoassay of cyclic AMP
Cells transfected as above were trypsinised and seeded
into 24-well plates at 200,000 cells per well the day
following transfection. Following a further 24 h incuba-
tion, the cells were stimulated in cell culture media
supplemented with 10 8 M melatonin in the presence of
10 mM 3-isobutyl-1-methylxanthine (IBMX) for various
time intervals at 37 jC. Reactions were terminated by
addition of trichloroacetic acid to a final concentration of
5%. Cyclic AMP levels were determined as reported
previously [15].
3. Results
3.1. Expression of Gas chimaeras in transfected cells
The human Gs-S1 form minus the C-terminal five
amino acids (positions 1–375) was obtained by PCR
using Pfu polymerase. Annealed oligos encoding the array
of C-terminal five amino acids were ligated to the blunt
Gs-S1 PCR product to give Gas and the Gas–ax
chimaeras listed (Fig. 1). Wild-type HEK293 cells express
both the S1 and S2 form of Gas. Overexpression of
transiently transfected wild-type Gas short form was
detectable as a 44 kDa protein at levels greater than
those of endogenous Gas as compared by Western blot-
ting of cells transfected with or without the recombinant
Gas using anti Gas (C-terminal) antibody (Santa Cruz)
(Fig. 2A). Signal detection of endogenous Gas was only
detectable after longer radiograph exposure. The endoge-
nous short form of Gas, S1, was expressed at lower
levels than S2 (unpublished observation). The Gai3 anti-
body used was able to detect overexpression of recombi-
nant Gas–ai3 chimaera subunits (44 kDa) in transfected
cells as distinct from endogenous Gai3 subunits (40.5
kDa) when compared with cells transfected with the
pGL3(CRE2-TK) plasmid only (Fig. 2B). Increased levels
of ribosylated G proteins were observed in cells trans-
fected with wild-type Gas or Gas–ax chimaeras com-
pared to non-transfected cells and cells transfected with
the pGL3(CRE2-TK) plasmid only (Fig. 2C). A 1-D
evaluation of Fig. 2C by AIDA Image Analyser software
(Raytest Isotopenmeßgerate GmBH, Germany) was per-
formed and confirmed an enhanced signal for ribosylated
short form Gs wt and Gs–x chimaeras in transfected
cells.
3.2. Activation of luciferase activity by MT1 and MT2
receptors via Gas chimeric coupling
Previous reports have indicated that melatonin receptors
inhibit cyclic AMP via PTX-sensitive G proteins of the Gi
family. Considering evidence that the C-terminal five
amino acids confer coupling specificity on G protein and
G protein-coupled receptor interactions, we tested the
array of Gas chimaeras (Fig. 1) to determine the coupling
profile of the human MT1 and MT2 receptors. The native
HEK293 cells and HEK293 cell lines stably expressing
the human MT1 (HEKh1a) and MT2 (HEKh1b) receptors
were transfected with the cyclic AMP responsive lucifer-
ase construct pGL3(CRE2-TK) alone or together with
Fig. 2. Expression of recombinant Gas wt and Gas chimaeras. The expression of the transfected Gas wt (A) and Gas–ai3 (B) chimaeras were ascertained by
immunoblotting 20 Ag of membrane protein with (A) anti-Gas (c-terminal) and (B) Gai3 (c-terminal) antibodies (Santa Cruz). Endogenous Gai3 is visible as a
40.5 kDa product as opposed to the 44 kDa Gas–ai3 chimaera. (C) Autoradiograph showing 32P-labelled products ribosylated with cholera toxin (120 Ag/ml)
in membranes of clonal cell line 3HEKh1a transiently transfected with the Gas–ax chimaeras. The ribosylated short form Gas–ax chimaeras are visible
above endogenous levels of short form Gas.
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wild-type Gas or Gas–ax chimaera constructs. The
luciferase activity was then measured as described above
in the presence or absence of 10 8 M melatonin (Fig. 3).
Transfected cells were seeded into 96-well plates to permit
four determinations of basal and melatonin-induced luci-
ferase activation. The basal level of luciferase in each
transfected cell population was used to calculate activation
levels expressed as a ratio (% over basal). Basal activity is
a measure of luciferase generation from the TK promoter
prior to stimulation via the CRE response elements. This
provides a means of determining that sufficient cells have
been transfected for the subsequent assay. Calculation of
ratios using this approach allow for variations in trans-
fection efficiency and luminescence generated between
experiments in the whole series. The ratios obtained were
generated from eight luciferase determinations from at
least three and up to eight different experiments (24–64
data points) to allow calculation of mean luciferase acti-
vation and standard errors. There was no significant
activation of luciferase activity in the native HEK293 cell
line using wild-type Gas or Gas–ax chimaeras (data not
shown). There was also no significant activation of luci-
ferase activity in the HEKh1a or HEKh1b cell lines
transfected with pGL3(CRE2-TK) alone or pGL3(CRE2-
TK) and Gas when compared to the basal levels of
luciferase in these transfected cells (Fig. 3A, B). In
contrast, luciferase activation was detected on co-trans-
fection with a number of the Gas–ax chimaeras. HEKh1a
cells showed melatonin-stimulated activation of luciferase
activity when transfected with Gas–aGi, Gas–aGi3
Gas –aGo, Gas –aGq, Gas –aGz, Gas –aG12 Gas –
aG13 Gas–aG14 Gas–aG16 indicating promiscuous
coupling of the human MT1 receptor to the Gas–ax
chimaeras (Fig. 3A). HEKh1b cells showed melatonin
activation of luciferase activity to varying degrees when
transfected with Gas–aGi, Gas–aGi3, Gas–aGz, Gas–
Fig. 3. Coupling profile of the human melatonin receptors MT1 (A) and
MT2 (B) with the Gas–ax chimaeras. The activation of luciferase activity
in each cell line co-transfected with the pGL3(CRE2-TK) reporter construct
(CRE) and the Gas–ax chimaeras was measured as the percentage above
basal after stimulation with 10 8 M melatonin over a period of 16–18 h.
Basal levels were obtained from transiently transfected cells that were
unstimulated. Values are the means of at least three separate transfections
assayed in quadruplicate.
Fig. 4. Dose response of melatonin activation of luciferase response in MT1
(A) and MT2 (B) expressing cell lines co-transfected with the pGL3(CRE2-
TK) reporter construct (CRE) and the Gas–ai chimaera. Values are the
means of at least three separate transfections assayed in quadruplicate.
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aG12, and to a lesser degree with Gas–aGo and Gas–
aG14 (Fig. 3B). Activation of Gas–aGq, Gas–aG13 or
Gas–aG16 was not achieved to a significant degree (Fig.
3B). Hence, the Gas–ax chimaeras were successful in
converting the usual melatonin cyclic AMP inhibitory
signal to a cyclic AMP stimulatory signal as measured
by luciferase activity. Potential activation of endogenous
cAMP inhibitory Gi proteins is possible in response to
the elevation of cAMP via melatonin receptor coupling
with Gas–ax. However, once the luciferase enzyme has
been synthesised from the activated reporter construct
pGL3(CRE2-TK) it will remain present and active for
many hours. Subsequent degradation of cAMP or its
inhibition by other cellular factors does not alter the
luciferase already activated via Gas –ax coupling.
Cyclic AMP inhibition via coupling of melatonin to
endogenous Gi subunits was not significant in radioimmu-
noassays of MT1 and MT2 expressing cells transfected
with the reporter plasmid only (see below). Forskolin was
used in early experiments to ensure transfection efficiency
was sufficient to give detectable levels of luciferase.
Forskolin stimulation was not subsequently used in all
of the assays as successful transfection could be ascer-
tained by the luciferase generated from the TK promoter.
Forskolin-induced luciferase activity up to 60% over basal
was achieved.
Dose response experiments were performed. Dose-
dependant stimulation of MT1 and MT2 receptors exhibited
the expected effect on luciferase activation when coupled to
Gas–ai chimaeras (Fig. 4). Differential coupling efficiency
of the melatonin receptors to the chimaeras was observed
with differences in activation apparent for different chimae-
ras and between the two receptors (see Fig. 3).
3.3. Radioimmunoassay of cyclic AMP
The ability of Gas–ax chimaeras to elevate cyclic AMP
via interaction with melatonin receptors and the assay sensi-
tivity was further assessed by performing radioimmunoassay
of cyclic AMP levels. Radioimmunoassay confirmed eleva-
tion of cyclic AMP levels in response to stimulation of MT1
receptors in cells transfected with Gas–ax chimaeras
(Fig. 5). Consistent with the luciferase reporter data,
increased cyclic AMP levels were not observed in cells
transfected with wild-type Gas. No significant cAMP inhib-
ition via endogenous Gi was detected in cells transfected with
the reporter plasmid only. This is consistent with previous
reports that melatonin does not significantly affect basal
levels of cAMP [27]. Extended incubation periods were
necessary to detect the full range of Gas–ax chimaera
coupling interactions predicted by the luciferase assay for
MT1 and MT2 receptors (unpublished observations).
Fig. 5. Measurement of cyclic AMP elevations by radioimmunoassay of HEKh1a transiently transfected with Gas–x chimaeras. Stimulations with 10 8 M
melatonin or 10 5 M forskolin were performed for 30 min in the presence of 10 3 M IBMX. The data shown is a representative experiment performed on
samples assayed in duplicate from three experimental replicates.
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4. Discussion
This study has illustrated the differential coupling of the
human melatonin receptors to the C-terminal five amino
acids of the known Ga proteins. Replacement of the C-
terminal five amino acids of Gas allowed paradoxical
stimulation of cyclic AMP by melatonin receptors. The
broad range of coupling and activation of Gas–ax chimae-
ras by the melatonin receptors and the comparative ease of
measuring signal activation via the CRE luciferase system
provides a useful tool to identify signal activation of Gai-
coupled receptors. Indeed the Gas–ai chimaera has been
used successfully to demonstrate melatonin binding to
chimeric melatonin and melatonin-related receptors
[28,29]. The work reported here has implications for the
study of signalling pathways activated by melatonin recep-
tors and the possibilities for complex G protein interactions
dependent on G protein profiles in different cell types. The
levels of receptor and Ga protein expression, the time
period of ligand activation and sub-localisation of receptors
and Ga proteins in the cell membrane may all be contribu-
ting factors to determining selection of G protein coupling.
The differential coupling of each receptor with the array of
possible Ga protein C-terminal five amino acids extends our
knowledge of the interaction of G protein-coupled receptors
with G proteins and may alter our perception of coupling
specificity.
Using the Gas–ax chimaeras, it was possible to
determine a coupling profile for the two human melatonin
receptor subtypes to the known Ga C-terminal five amino
acids by monitoring cyclic AMP induction via coupling of
each receptor subtype to the Gas–ax chimaeras. The data
suggest a strong interaction of the MT1 and MT2 receptors
with Gi. This is entirely consistent with published data
showing that melatonin receptors exhibit cyclic AMP
production in a PTX-sensitive manner. The interaction
between the MT1 receptor and Gz is also anticipated, as
receptors that couple to Gi often couple Gz. Gz subunits
inhibit cyclic AMP in a PTX-insensitive manner and may
account for reports of coupling via the PTX-insensitive
cyclic AMP inhibitory G proteins [17,18,30]. The obser-
vation of differential coupling efficiencies of MT1 and
MT2 receptor subtypes may have implications for the
differential expression of these receptors in vivo. Exten-
sive experiments investigating the interaction of the Gas–
ax chimaeras with MT1 and MT2 receptors also exhibit
differences that appear to be dependant on the method
used to measure signal output. The luciferase assay and
radioimmunoassay exhibit differences in temporal and
kinetic parameters of the cyclic AMP responses. IBMX
is incorporated in the radioimmunoassay to inhibit cyclic
AMP phosphodiesterase. If only small elevations in cyclic
AMP are generated, it may take several hours to produce
detectable accumulations. The luciferase luminescent
response is inherently more sensitive and is capable of
measuring a wide range in the elevation of cyclic AMP
levels. The luciferase luminescent system is also respon-
sive irrespective of whether the response is large and
transient (acute) or prolonged with small elevations
(chronic). Providing the acute response is sufficiently
large, the luciferase produced should be measurable hours
later. Alternatively, a chronic effect should provide a
steady accumulation of luciferase over a sufficient incu-
bation period. Hence, the CRE luciferase reporter system
used in these studies has the capacity to detect a broad
range of cellular responses that may be acute or chronic.
The CRE luciferase reporter system has the broad detec-
tion range necessary for detection of both the large acute
responses induced by MT1 and MT2 coupling to Gas–i
chimaeras and the chronic responses via coupling of those
Gas–x chimaeras that couple less efficiently. The low
levels of cyclic AMP induction by the latter would be
difficult to detect by conventional radioimmunoassay of
cyclic AMP but are detectable by the CRE-luciferase
reporter system that detects luciferase accumulated over
the 16 h incubation period. Thus there are important
differences in the temporal and kinetic parameters of the
cyclic AMP responses and these may influence and
account for the different end responses observed. Further-
more, we conclude that the C-terminal five amino acids
are not the sole determinants of coupling specificity.
Indeed, there have been a number of recent reports
revealing further complexities of determinants of G protein
receptor coupling [31,32]. However, recognition of the C-
terminal five amino acids is an important requisite in the
system outlined here.
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